Chargement en cours...
Phase II trial of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehydethiosemicarbazone plus gemcitabine in patients with advanced biliary tract cancer
BACKGROUND: 3-Aminopyridine-2-carboxaldehydethiosemicarbazone (3-AP) is a novel small molecule ribonucleotide reductase (RR) inhibitor which is more potent than hydroxyurea, the prototype of RR inhibitors. 3-AP enhances the cellular uptake and DNA incorporation of gemcitabine in tumor cell lines. We...
Enregistré dans:
Auteurs principaux: | , , , , , , , , , , , |
---|---|
Format: | Artigo |
Langue: | Inglês |
Publié: |
2010
|
Sujets: | |
Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3446256/ https://ncbi.nlm.nih.gov/pubmed/20981545 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-010-1481-z |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|